Patients treated within your trust
Dear Betsi Cadwaladr University Health Board,
The following questions with regards to patients treated in your trust are being asked for on behalf of Novartis.
1) In total, over the past 4 months, how many patients have been treated for the following diseases (Rheumatoid arthritis, Axial Spondyloarthritis, Psoriatic arthritis, Psoriasis, hidradenitis suppurativa)?
2) Of these five, how many of each received the following products:
- Adalimumab (Humira)
- Adalimumab Biosimilar
- Etanercept (Enbrel)
- Etanercept Biosimilar
- Infliximab (Remicade)
- Infliximab biosimilar
- Golimumab (Simponi)
- Tofacitinib (Xeljanz)
- Ustekinumab (Stelara)
- Vedolizumab (Entyvio)
- Filgotinib (Jyseleca)
- Abatacept (Orencia)
- Baricitinib (Olumiant)
- Certolizumab Pegol (Cimzia)
- Rituximab (MabThera)
- Rituximab Biosimilar
- Tocilizumab (RoActemra)
- Sarilumab (Kevzara)
- Apremilast (Otezla)
- Secukinumab (Cosentyx)
- Isekizumab (Taltz)
- Guselkumab (Tremfya)
- Brodalumab (Kyntheum)
- Risankizumab (Skyrizi)
- Tildrakizumab (Ilumetri)
- Upadacitinib (Rinvoq)
- Bimekizumab (Bimzelx)
3) Could you please provide the number of these patients that were treated within the gastro department (still split by disease and treatment).
4) Over the same time period, how many patients for each of the five diseases (Rheumatoid arthritis, Axial Spondyloarthritis, Psoriatic arthritis, Psoriasis, hidradenitis suppurativa) received the following treatments as their first ever biologic treatment?
- AxSPA
- PsA
- PsO
Thank you for taking the time to answer these questions, and I look forward to your response.
Yours faithfully,
Oliver Caswell
Dear Oliver Caswell,
Thank you for your request below. This request is being handled under the Freedom of Information Act 2000, please find enclosed our leaflet providing guidance on our procedure for managing requests.
I would like to confirm that your request is being processed and we will write to you shortly. A final decision on your request would normally be sent to you within 20 working days of receipt of your request. This means that you can expect to receive your decision by 02nd August.
We welcome correspondence through the medium of Welsh.
Many thanks,
Jenna Hughes
Trainee Information Governance Administrator
Gweinyddwr Llywodraethu Gwybodaeth Dan Hyfforddiant
Pob ymholiad / cais i gael ei gofnodi ar y porth Llywodraethu Gwybodaeth:
https://ictportal.cymru.nhs.uk/governance
All queries / requests to be logged on the Information Governance portal:
https://ictportal.cymru.nhs.uk/governance
Ffon/Tel: 03000 858361
P Help save paper – do not print this message unless necessary!
P Arbedwch bapur - peidiwch ag argraffu'r neges hwn onibai ei fod yn hollol angenrheidiol os gwelwch yn dda!
We welcome correspondence through the medium of Welsh
Rydym yn croesawu gohebiaeth drwy gyfrwng y Gymraeg
Dear Oliver Caswell,
Further to your recent request for information under the Freedom of Information Act, please find attached our response.
Kind regards,
Kushla Everett-Kingston
Swyddog Llywodraethu Gwybodaeth / Information Governance Officer
Betsi Cadwaladr Bwrdd Iechyd Prifysgol/University Health Board
Pob ymholiad / cais i gael ei gofnodi ar y porth Llywodraethu Gwybodaeth:
All queries / requests to be logged on the Information Governance portal: https://ictportal.cymru.nhs.uk/governance
My usual base is Ysbyty Gwynedd but due to COVID-19 working arrangements, I am
currently working from home. Please contact me either by email or Microsoft Teams as I
have no office landline available to me.
Os ydych angen cymorth brys ffoniwch / general office number 03000 858361
We welcome correspondence through the medium of Welsh
Rydym yn croesawu gohebiaeth drwy gyfrwng y Gymraeg
Ffôn/Tel: 03000 858361
P Help save paper – do not print this message unless necessary!
P Arbedwch bapur - peidiwch ag argraffu'r neges hwn onibai ei fod yn hollol angenrheidiol os gwelwch yn dda!
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now